Common Errors in Disk Diffusion Testing and How to Avoid Them

Disk diffusion (Kirby-Bauer) testing is a standardized antimicrobial susceptibility testing (AST) method where antibiotic-impregnated paper disks are placed on an agar plate inoculated with a bacterial suspension; after incubation, the diameter of the inhibition zone around each disk is measured and compared to established breakpoints to determine susceptibility or resistance. This method is useful for routine clinical and research laboratories performing phenotypic AST, particularly when screening multiple antibiotics simultaneously, and remains a cost-effective alternative to broth microdilution for many bacterial isolates. However, disk diffusion is highly sensitive to procedural variables that can produce inaccurate results. This article identifies the most frequent errors in disk diffusion testing—including inoculum density, agar depth, disk placement, and reading inconsistencies—and provides evidence-based strategies to avoid them, based on CLSI and EUCAST guidelines.

At a Glance

Scientific Principle of Disk Diffusion

Disk diffusion testing relies on the diffusion of an antibiotic from a paper disk into the surrounding agar medium, establishing a concentration gradient. Bacterial growth on the agar surface is inhibited where the antibiotic concentration exceeds the minimum inhibitory concentration (MIC) for that organism. The resulting zone of inhibition diameter is inversely proportional to the MIC: larger zones indicate greater susceptibility, while smaller or absent zones suggest resistance. The test is standardized by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST), which provide specific breakpoints for interpreting zone diameters as susceptible, intermediate, or resistant.

The method's reproducibility depends on controlling variables that affect antibiotic diffusion (agar composition, depth, pH) and bacterial growth (inoculum density, incubation conditions). As noted in recent research, disk diffusion for certain antibiotics like cefiderocol is "highly sensitive to factors such as media composition and the presence of atypical colony morphology" [1]. This sensitivity underscores the need for rigorous standardization across all procedural steps.

Materials and Instrumentation Choices

Agar Medium Selection

Mueller-Hinton agar (MHA) is the standard medium for disk diffusion testing of non-fastidious bacteria. Key considerations include:

• Agar depth: The recommended depth is 4 mm ± 0.5 mm. For a standard 100 mm Petri dish, this requires 25 mL of molten agar. Deeper agar reduces antibiotic diffusion, producing falsely small zones; shallower agar produces falsely large zones. Measure depth periodically using a sterile ruler or caliper.
• Agar composition: Variations between manufacturers can affect results. A study evaluating cefiderocol disk diffusion found that "variability in inhibition zone diameters was observed between media, notably with chromogenic agar," and that "the most consistent results were obtained using Graso Biotech and Thermo Fisher Columbia with blood agar" [1]. For routine testing, use MHA from a reputable manufacturer and validate each new lot against control strains.
• Supplementation: For fastidious organisms (e.g., Haemophilus influenzae, Neisseria gonorrhoeae), use supplemented MHA (e.g., with 5% sheep blood, NAD, or specific growth factors) as specified by CLSI/EUCAST.

Disk Selection and Storage

• Commercial disks: Use disks from reputable manufacturers with documented potency. Store disks at -20°C or 4°C in sealed containers with desiccant, as specified by the manufacturer. Allow disks to reach room temperature before opening to prevent condensation.
• Disk dispenser: Use a calibrated disk dispenser or sterile forceps for manual placement. Avoid touching the disk surface with forceps; grasp the edge only.

Inoculum Preparation Equipment

• McFarland standard: Use a 0.5 McFarland turbidity standard (equivalent to ~1.5 × 10⁸ CFU/mL for E. coli). Prepare fresh or use a commercial standard. Verify turbidity with a nephelometer or spectrophotometer (absorbance at 625 nm: 0.08-0.13 for 0.5 McFarland).
• Saline or broth: Use sterile 0.85% saline or Mueller-Hinton broth for suspension preparation. Do not use water, which can lyse bacteria.

Controls and Quality Assurance

Daily Quality Control Strains

Run QC strains with each batch of tests to validate the system. Recommended ATCC strains include:

• Escherichia coli ATCC 25922 (for most antibiotics)
• Staphylococcus aureus ATCC 25923 (for Gram-positive antibiotics)
• Pseudomonas aeruginosa ATCC 27853 (for aminoglycosides and antipseudomonal agents)
• Enterococcus faecalis ATCC 29212 (for vancomycin and high-level aminoglycosides)

Document zone diameters for each QC strain and compare to CLSI/EUCAST acceptable ranges. If any QC result falls outside the range, investigate and correct the error before reporting patient results.

Media Quality Control

• Sterility check: Incubate one uninoculated plate from each batch at 35°C for 24-48 hours to confirm no contamination.
• pH check: MHA pH should be 7.2-7.4 at room temperature. Use a surface pH electrode or pH paper. Incorrect pH can alter antibiotic activity (e.g., tetracyclines are less active at low pH).
• Depth check: Measure agar depth in at least three plates per batch using a sterile ruler. Reject plates with depth outside 3.5-4.5 mm.

Conceptual Workflow

Step 1: Inoculum Preparation

1. Select 3-5 isolated colonies from an 18-24 hour culture on non-selective agar.
2. Transfer colonies to 3-5 mL sterile saline or broth using a sterile loop or swab.
3. Vortex or mix thoroughly to create a uniform suspension.
4. Adjust turbidity to 0.5 McFarland using a nephelometer or by visual comparison against a standard. Common error: Over-inoculation (too turbid) produces falsely small zones; under-inoculation produces falsely large zones.
5. Use the suspension within 15-30 minutes to avoid bacterial multiplication or death.

Step 2: Inoculation of Agar Plate

1. Dip a sterile cotton swab into the adjusted suspension.
2. Rotate the swab against the tube wall above the liquid to remove excess fluid.
3. Streak the swab evenly across the entire agar surface in three directions (horizontal, vertical, diagonal) to ensure confluent growth.
4. Rotate the plate 60° between each streaking direction.
5. Allow the plate surface to dry for 3-5 minutes (no longer than 15 minutes) before applying disks.

Step 3: Disk Application

1. Apply disks within 15 minutes of inoculation using a dispenser or sterile forceps.
2. Press each disk gently onto the agar surface with sterile forceps to ensure full contact.
3. Space disks at least 24 mm apart (center-to-center) and ≥15 mm from the plate edge. For a 150 mm plate, place no more than 12 disks; for a 100 mm plate, no more than 6 disks.
4. Common error: Placing disks too close together can cause overlapping inhibition zones, making measurement impossible or producing falsely small zones due to antibiotic interference.

Step 4: Incubation

1. Invert plates and incubate at 35±2°C for 16-18 hours in ambient air.
2. For fastidious organisms, use appropriate atmosphere (5% CO₂ for H. influenzae, N. gonorrhoeae) and extended incubation (20-24 hours).
3. Common error: Incubating in CO₂ for non-fastidious organisms can lower medium pH, affecting antibiotic activity (e.g., aminoglycosides become less active, producing falsely small zones).

Step 5: Zone Measurement

1. Measure zone diameters to the nearest millimeter using a ruler, caliper, or automated zone reader.
2. Read from the back of the plate against a dark background with reflected light.
3. Measure the diameter of the complete inhibition zone, including the disk diameter (6 mm).
4. For swarming organisms (e.g., Proteus spp.), measure the zone edge where growth is inhibited, ignoring the swarming haze.
5. Common error: Including faint growth or microcolonies within the zone (especially with trimethoprim-sulfamethoxazole or β-lactams) can produce falsely small zones. Read at the sharp edge of growth inhibition.

Step 6: Interpretation

1. Compare measured zone diameters to current CLSI or EUCAST breakpoint tables.
2. Classify as Susceptible (S), Intermediate (I), or Resistant (R).
3. For results falling in the "Area of Technical Uncertainty" (ATU) per EUCAST, repeat the test or confirm by MIC method.

Quality Checks and Troubleshooting

Routine Quality Checks

• Daily: QC strains with each test batch; document zone diameters.
• Weekly: Check incubator temperature and CO₂ levels; verify McFarland standard against a reference.
• Monthly: Review QC trends for shifts or drifts; recalibrate nephelometer.
• Per batch: Sterility check of media; pH and depth verification.

Troubleshooting Table

Result Interpretation and Documentation

Recording Results

• Record zone diameters in millimeters for each antibiotic-organism combination.
• Document the breakpoint table used (CLSI M100 or EUCAST v.X.X) and the year/version.
• Note any technical issues (e.g., swarming, haze, overlapping zones) and how they were resolved.
• For results in the ATU, document the repeat test result or the MIC confirmation.

Common Interpretation Pitfalls

• Using outdated breakpoints: CLSI and EUCAST update breakpoints annually. Always use the most current version.
• Misreading zone edges: For antibiotics that produce a "ghost zone" (e.g., oxacillin with S. aureus), read the inner edge of heavy growth, ignoring faint haze.
• Ignoring colony morphology: As noted in the cefiderocol study, "isolated colonies were observed in over half the samples and, depending on how they were interpreted, led to major changes in classification accuracy" [1]. Always examine the plate for isolated colonies within the zone and interpret according to standard guidelines.

Documentation Requirements

• Test date and operator initials
• Organism identification and source
• Inoculum turbidity verification method
• Medium lot number and expiration date
• Disk lot numbers and expiration dates
• Incubation conditions (temperature, time, atmosphere)
• QC strain results and acceptability
• Zone diameters for each antibiotic
• Interpretation (S/I/R) with breakpoint reference
• Any deviations from standard protocol

Limitations and Edge Cases

Known Limitations

• Not suitable for slow-growing organisms: Disk diffusion requires visible growth within 16-18 hours. For slow growers (e.g., Mycobacterium spp., anaerobes), MIC methods are preferred.
• Cannot detect heteroresistance: Subpopulations with reduced susceptibility may grow within the zone, requiring MIC confirmation.
• Semi-quantitative: Provides categorical results (S/I/R) rather than exact MIC values. For dose optimization, MIC methods are needed.
• Media-dependent: As demonstrated with cefiderocol, "disk diffusion for cefiderocol may be used in resource-limited settings but only if rigorously standardized using validated media, consistent zone reading, and ATU-a" [1].

Edge Cases

• Mixed cultures: If two colony types appear, re-isolate and test each separately.
• Mucoid organisms: Pseudomonas aeruginosa mucoid variants may produce indistinct zone edges; use a swab to remove excess mucoid material before reading.
• Antibiotic combinations: Disk diffusion cannot assess synergy or antagonism; use checkerboard or time-kill assays.
• Non-standard antibiotics: For novel compounds, "significant variability in the outcomes depending on the method used, especially for substances with intrinsic" properties [2] may require multiple methods for validation.

Biosafety Considerations

Disk diffusion testing is typically performed at Biosafety Level 2 (BSL-2) for clinical isolates, but routine teaching laboratories using non-pathogenic strains (e.g., E. coli ATCC 25922, S. aureus ATCC 25923) may operate at BSL-1 with appropriate precautions [4]. Key biosafety practices include:

• Hand hygiene: Wash hands before and after handling cultures.
• Personal protective equipment: Wear lab coats, gloves, and eye protection when handling bacterial suspensions.
• Work surface decontamination: Clean benches with 10% bleach or 70% ethanol before and after each session.
• Waste disposal: Autoclave all contaminated materials (plates, swabs, pipette tips) before disposal.
• Spill management: Cover spills with absorbent material, apply disinfectant, allow 20-minute contact time, then clean.
• Sharps safety: Use plastic Pasteur pipettes; dispose of glass in sharps containers.
• Training: Ensure all personnel are trained in BSL-2 practices and understand the risks of the organisms being tested [5].

For recombinant or synthetic nucleic acid work (e.g., testing engineered strains), follow NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [5].

Frequently Asked Questions

Q1: Why do my zone diameters vary between different brands of Mueller-Hinton agar?

Different manufacturers may use slightly different agar formulations (e.g., cation content, agar concentration) that affect antibiotic diffusion and bacterial growth. This is particularly critical for certain antibiotics like cefiderocol, where "variability in inhibition zone diameters was observed between media" [1]. To minimize variation, use a single validated brand for routine testing, and verify each new lot with QC strains before use.

Q2: How should I read zones when there is a haze of growth or isolated colonies within the inhibition zone?

For most antibiotics, read the zone at the sharp edge of heavy growth, ignoring faint haze or isolated colonies. However, for trimethoprim-sulfamethoxazole and some β-lactams, microcolonies within the zone may indicate heteroresistance. In such cases, measure the zone at the edge of the heaviest growth and note the presence of colonies. If isolated colonies are present, as observed in over half of cefiderocol tests [1], repeat the test or confirm by MIC method.

Q3: Can I use disk diffusion for fastidious organisms like Haemophilus influenzae or Neisseria gonorrhoeae?

Yes, but only with specific modifications: use supplemented MHA (e.g., with 5% sheep blood and NAD for H. influenzae), incubate in 5% CO₂, and extend incubation to 20-24 hours. Use the appropriate CLSI or EUCAST breakpoints for these organisms. Note that CO₂ incubation lowers medium pH, which can affect antibiotic activity, so always run QC strains under the same conditions.

Q4: What should I do if my QC strain results are consistently out of range?

First, check the most common causes: verify the McFarland standard (recalibrate or replace), measure agar depth (should be 4 mm), check incubator temperature (35±2°C), and confirm disk potency (check expiration dates and storage conditions). If these are correct, test a new lot of medium and a new lot of disks. If the problem persists, contact the manufacturer or consult CLSI M100 for troubleshooting guidance.

References and Further Reading

1. Saar M, Wawrzyk A, Pastuszak-Lewandoska D, Bielec F. Cefiderocol Antimicrobial Susceptibility Testing by Disk Diffusion: Influence of Agar Media and Inhibition Zone Morphology in K. pneumoniae Metallo-β-lactamase. 2025. PubMed ID: 40426593. https://pubmed.ncbi.nlm.nih.gov/40426593/ — Demonstrates media-dependent variability and the importance of standardized zone reading for disk diffusion.

2. Puxeddu S, Canton S, Scano A, et al. Beyond One-Size-Fits-All: Addressing Methodological Constraints in Novel Antimicrobials Discovery. 2025. PubMed ID: 40868042. https://pubmed.ncbi.nlm.nih.gov/40868042/ — Highlights variability between AST methods and the need for multiple approaches.

3. Saha S, Khan AM, Haque FKM. Microbiological quality assessment of potential pathogenic bacteria and multidrug resistance patterns in commercial electrolyte drinks in Dhaka, Bangladesh. 2026. PubMed ID: 42228720. https://pubmed.ncbi.nlm.nih.gov/42228720/ — Illustrates disk diffusion application in food safety surveillance.

4. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. https://www.cdc.gov/labs/bmbl/index.html — Authoritative biosafety guidelines for laboratory practice.

5. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ — Biosafety framework for recombinant work.

6. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ — Searchable collection of biomedical methods references.

Related Articles

• Common Sources of Error in Disk Diffusion Susceptibility Testing and How to Avoid Them
• Disk Diffusion Method for Antimicrobial Susceptibility Testing: Protocol and Interpretation
• How to Interpret Zone Diameter Measurements in Disk Diffusion Susceptibility Testing
• Understanding CLSI Breakpoints for Disk Diffusion and MIC Interpretation
• How to Design a Reproducible Disk Diffusion Susceptibility Test Protocol
• How to Calculate the Number of Bacteria Using the Kirby-Bauer Disk Diffusion Method